New diabetes clinical trial: NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Published on: 2026-09-15T04:00:00Z
Conditions: Type 2 Diabetes; Coronary Heart Disease; Myocardial Infarction; Cerebrovascular Disease; Stroke; Chronic Kidney Disease; Fatty Liver Disease
Interventions: Behavioral: Digital health interventions
Sponsors: University of Eastern Finland; Sitra, the Finnish Innovation Fund; Wellbeing Services County of South Savo (Eloisa); Nightingale Health Plc
Not yet recruiting
https://ift.tt/Cm2gLnF